60 Degrees Pharmaceuticals shares surged 161% pre-market after partnering with Runway Health to expand access to its malaria drug Arakoda. The FDA-approved, once-weekly treatment will be offered to international travelers through Runway platform starting April 2, 2026, with prescriptions tailored by licensed providers.